# Grok Genome — Development History

**Repository:** [smeagster86/grok-genome](https://github.com/smeagster86/grok-genome)  
**Default branch:** main  
**Current HEAD (as of this handoff update):** `7f0408cb29914554a503f8ed7246367cb01cace0` (initial GitHub publish + full handoff preparation for cross-machine Grok Builder resumption, late May 2026)

> This document exists so that future Grok sessions (or human contributors) can read the complete story instead of losing critical context across conversation boundaries, context compactions, or hand-offs. It is the authoritative reference for the project's philosophy, guardrails, roadmap decisions, technical patterns, and hard-won build/deployment lessons.

---

## CURRENT STATUS & FORWARD PLAN FOR RESUMPTION (Handoff for cross-machine / cross-session sign-off — late May 2026)

**Project Genesis + Handoff Snapshot:** This commit (`7f0408c...`) is the complete initial public release on GitHub. It captures the full output of the first Grok Builder session: all core phases (Evidence → Profiles → Trust Architecture → Beta Readiness), the full 5-expert critical appraisal synthesis (Phase 5), Tier 1 refinements, simulator redesign, and handoff documentation. 

Intended for immediate resumption in a *new* Grok Builder session (different machine or later time) to begin Tier 2 work with zero context loss. The "sign-off" framing below is retained verbatim from the originating user request that triggered this handoff preparation.

**All work completed so far (full Phase 5 expert-driven refinements):**

The project has completed the core four phases (Evidence → Profiles → Trust Architecture → Beta Readiness) plus a deliberate Phase 5 of top-of-field expert critical appraisal and targeted refinement.

- Commissioned and synthesized 5-expert critical appraisals (bioethicist/population genetics Okoro, sleep/circadian Reyes, statistical genetics/PRS Vargas, pharmacogenomics Hale, nutrition/metabolism Sharma). Raw reports saved in `EXPERT_CRITICAL_APPRAISALS_2026-05-27.md` (77 KB).

- **Tier 1 high-consensus items** executed systematically, one at a time, with repeated full user approvals ("Yes please proceed", "full approvals", "I think execute step 3", "Yes please move to this next priority item", etc.):

  - **Step 1 – Ancestry transparency** (Tier 1): Prominent global amber banner on all results ("Important: Most genetic associations in this report are based primarily on European-ancestry studies. Applicability to other ancestries may be limited or unknown...") + extended EvidenceBadge with `population` prop + strengthened language in every profile + dedicated "Ancestry & PRS Limitations" section (expert synthesis: Martin/McVean/Wang views on European bias, 30–70% PRS portability drop, "one small, probabilistic data point") integrated into `/for-clinicians` and PDF Report Overview.

  - **Step 2 – Gene–environment dominance + grounded usefulness** (Tier 1): Amber "Gene–Environment Context" callout boxes added to all 4 profiles (and clinicians/exports). Consistent framing: environmental factors (diet quality, light hygiene, schedules, stress, medications, age, etc.) typically explain the large majority of real-world variance for the traits discussed. The genetic signals surfaced here are one small, probabilistic contribution at best.

  - **Step 3 – Reframe weak-signal profiles per expert appraisals** (DrugMetabolismTendencies + SleepRecoveryContext): Explicit "toy model / educational illustration only" language, quantitative humility (sleep 3-SNP model <<2% variance in large datasets; large polygenic scores for chronotype ~5–8% R² even in Europeans; 90%+ of differences environmental/behavioral/clinical), concrete modifiable levers (morning bright light 30–60 min after waking + dim evening lighting can shift timing 1–3+ hours; social jetlag of 1–2 hours often dwarfs genetics; "behavior usually moves the needle far more"), stronger "what this cannot tell you" framing. Exact 5Qs + probabilistic guardrails preserved. New file SHAs: Drug `ea205b968372276e4fa1d36be39ad3c53f000ecb` (commit `8024984d...`), Sleep `9c5b78277b1d7b41a0d5fe6c3681ebd53c684367` (commit `bc7dadac...`).

- **Educational simulator redesign** (Phase 5 follow-up per expert consensus to avoid anchoring/illusion of precision on weak signals): Removed broad "ILLUSTRATIVE GENETIC WELLNESS INDEX" 0-100 gauge + heuristic (mixed high-evidence PGx with exploratory nutrition/sleep SNPs). Replaced with narrow **"EDUCATIONAL PGx TOY MODEL — High-Evidence Pharmacogene Signals Only"** card (scoped to CYP2C19*2, VKORC1, etc.), dominant 92%/8% 90%+ environment/clinical/behavior bar with tiny genetic sliver, explicit "toy model for education / illustration — not a prediction of your response", concrete levers, "what this cannot tell you", scoped simulation only. Updated feature bar text. New page SHA `8b02239bc11dd6e13174c63544be8025af5b3ed2` (on this handoff commit `7f0408cb...`).

All guardrails strictly upheld throughout: exact 5 core questions structure for every profile, probabilistic/humility language only ("one data point among many", "toy model for educational illustration only", "typically explain the large majority", "consult your prescriber/clinician"), 100% client-side execution, no genomic data ever stored or transmitted, EvidenceBadge with population applicability notes on every finding, full Limitations panels, trust footers linking to Our Approach and For Clinicians.

**Live state on GitHub main (HEAD 7f0408cb29914554a503f8ed7246367cb01cace0):**

Fresh file SHAs (as of this handoff update):
- `app/page.tsx`: `8b02239bc11dd6e13174c63544be8025af5b3ed2` (narrow high-evidence PGx toy model + global ancestry banner + full Phase 4/5 wiring)
- `components/profiles/DrugMetabolismTendencies.tsx`: `ea205b968372276e4fa1d36be39ad3c53f000ecb` (Step 3 reframed with toy model / 90%+ clinical dominance)
- `components/profiles/SleepRecoveryContext.tsx`: `9c5b78277b1d7b41a0d5fe6c3681ebd53c684367` (Step 3 reframed with explicit toy model / <<2% variance / concrete levers)
- `components/profiles/MethylationSupport.tsx`: `1308c00ad15cf109bf932c5056529a0f36161603`
- `components/profiles/NutritionMetabolismContext.tsx`: `e7cecae93743500a2495851a1fc41981864621f2`
- `app/for-clinicians/page.tsx`: `8c6a057dcb6bc594b7d7675d5569f42a3c7bc899` (full "Ancestry & PRS Limitations" expert synthesis section)
- `lib/pdfExport.ts`: `d7292fe42abcd9f0966c971ea098dbd7eab528a4` (strengthened Report Overview with ancestry language)
- `lib/exportUtils.ts`: `ef803710be6ff9dd84eed251fd8be68002be0f53` (richer Phase 4/5 profiles in Markdown/JSON)
- `README.md`: `f46040e3e023ecbdf602a65d45413cf72bb7b504`
- `DEVELOPMENT_HISTORY.md`: `dcb54a143eb98fcbe037c6d0c1a7256a11408e14` (this file)

**Forward plan — Tier 2 items from the 5-expert critical appraisals** (user directive: "Yes please do those tier 2 items"):

These are the remaining high-value, low-risk refinements synthesized directly from the expert reports (strong consensus from Reyes, Vargas, Hale, Sharma). Implement systematically, one slice at a time, circling back for user review after each major piece. Preserve all existing guardrails (exact 5Qs, probabilistic language only, client-side only, etc.).

1. **Quantitative variance anchors / uncertainty disclosure** (Reyes/Vargas/Hale language): Add explicit phrases such as "<<2% of variance", "5–8% R²", "one small, probabilistic data point among many", "large majority (typically 90%+) from environment/clinical/behavioral factors", "genetic slice is typically minutes or less" across the 4 profiles (especially in the Gene–Environment boxes and Limitations lists), the narrow PGx toy model card in results, Report Overview, Markdown/PDF exports, and for-clinicians. Add natural-frequency framing.

2. **Population distribution visualizations + side-by-side comparisons**: Add simple bell-curve or variance visualizations (or clear textual equivalents) showing the tiny genetic slice + huge overlap with environment/behavior. Explicit comparisons (e.g., "your genetic nudge is typically minutes or less vs. one week of late screens or social jetlag shifting timing by 1–3+ hours").

3. **"What this cannot tell you" footers + gene × environment emphasis cards**: Consistent footers with natural frequencies + prompt to "track real-world data (sleep diary, wearable midpoint, symptoms, medication response, etc.) over 2–4 weeks alongside any genetic context". Concrete, actionable gene × environment cards with specific modifiable levers (morning bright light within 30–60 min of waking + dim evening lighting; consistent schedules; stress management; light hygiene; etc.) and cross-profile links.

4. **Lightly surface FTO/TCF7L2 in Nutrition + PGx Tier 2 details**: In NutritionMetabolismContext, lightly call out the well-known FTO (rs9939609) and TCF7L2 signals with heavy "environment dominates by far" framing (per Sharma). For PGx, add guideline status differentiation (CPIC/FDA-supported vs. exploratory), small conditional sub-boxes for DPYD, TPMT/NUDT15, HLA notes where relevant. Stronger visual/textual separation of strong vs. weak signals across the board.

**How to resume in a new Grok Builder session (any machine):**

1. In the new Grok Builder instance, open / clone the `smeagster86/grok-genome` repo (or let Grok Builder auto-connect to it via your GitHub account).
2. **Immediately read this DEVELOPMENT_HISTORY.md from the very top** — especially:
   - The "CURRENT STATUS & FORWARD PLAN FOR RESUMPTION" section (this one)
   - Executive Summary
   - Core Philosophy & Guardrails
   (Allow 5–10 minutes. This is the single source of truth.)
3. Confirm you are on the `main` branch and that the working tree matches HEAD `7f0408cb...`.
4. **Next immediate work (Tier 2):** Begin slice 1 — "Quantitative variance anchors / uncertainty disclosure" — systematically, one profile or export surface at a time. Use the exact expert-sourced language in the plan above. Create a todo list (exactly one item `in_progress` at a time per the implementer's discipline). After completing a slice, present the diff + rendered preview and wait for explicit user approval before the next slice.
5. All guardrails from the first session are non-negotiable and must be upheld without exception.

This single file + the raw `EXPERT_CRITICAL_APPRAISALS_2026-05-27.md` + the code on `main` give any future Grok Builder session (or human contributor) everything required for perfect continuity. No conversation history needed.

**Originating user request (late May 2026):** "Could you update the github in a way so there is a clear idea of all you've done so far, and the plan to continue going forward if I were to sign out of this grok builder instance and log in from my grok builder app on my home computer? I have to sign off from work quite shortly here." + explicit directive "Yes please do those tier 2 items".

This document is the direct response: a complete, self-contained handoff artifact published as the initial commit so the next Grok Builder session can begin Tier 2 work instantly with full fidelity.

---

## Executive Summary

Grok Genome is a **100% client-side, privacy-first Next.js 15 + TypeScript + Tailwind + Framer Motion** web application for exploring raw DNA data files (23andMe, MyHeritage, Ancestry, VCF, etc.). It provides curated SNP-level insights plus four rich synthesized profiles (Methylation Support, Drug Metabolism Tendencies, Nutrition & Metabolism Context, Sleep & Recovery Context) that strictly follow a probabilistic, humble, evidence-transparent framing.

The project began as an entirely different Windows automation tool for clinical note transfer and underwent an abrupt full pivot toward deeper, more thoughtful personal genomic analysis. It was then built through four deliberate phases (Evidence → Synthesis/Profiles → Trust Architecture → Beta Readiness) under extremely strict physician positioning guardrails. All genomic data never leaves the user's browser; only localStorage is used for non-genomic UI state (disclaimer dismissal + optional feedback). Exports (PDF, Markdown, JSON, CSV) carry the same humility language.

As of late May 2026, the site features consistent EvidenceBadge usage with population applicability notes, deepened Phase 4 profiles with Why boxes + 5–7 nuanced limitations each, a dedicated `/for-clinicians` route, a global first-visit disclaimer banner, local-only feedback, improved PDF Report Overview + page-break logic, a full cascade of production build fixes, Step 3 profile reframes (toy model/90%+ dominance for weak-signal profiles), and the educational simulator redesign (narrowed to high-evidence PGx toy model only).

**Core non-negotiables (never compromised):** exact 5-question structure per profile, probabilistic language only ("tendency", "one data point among many", "not deterministic", "consult professionals"), client-only execution, EvidenceBadge transparency on ancestry bias and effect size, and GA4GH-inspired ethical framing.

---

## Project Origin & Pivots

### Timeline of Major Shifts

- **Very early conversation:** User requested a completely different project — a multi-agent local Windows automation system (mouse/scroll monitoring via PyAutoGUI/Selenium, safe RL agents) to copy clinical notes from the standalone Heidi AI scribe into Accuro EMR for 10 family physicians on a tight budget.
- User researched paid Accuro/QHR integration options.
- User explicitly directed: "please proceed with the scaffolding for the extension" (heidi-accuro-bridge folder was started locally with manifest.json, background.js, content scripts, popup, etc.).
- **Abrupt full pivot:** The conversation returned to the user's existing Grok Genome personal genomics explorer. The request was to make the analysis much more exhaustive, produce a much more detailed report, add export options, and develop the site to support thoughtful and genuinely useful personal perspective when analyzing one's own genetic data — seeking clearer insight rather than any commercial direction.

The pivot was total and immediate. All prior automation scaffolding was abandoned in favor of deepening the existing Grok Genome site as a tool for careful, humble, and personally meaningful exploration of genetic information.

**Key early directive (physician positioning document, provided verbatim by user):** 
> "Private genomic intelligence for the individual, not a diagnostic service."

This single sentence, together with the strict 5 core questions structure and heavy emphasis on probabilistic/humility language, became the immovable foundation for every subsequent decision.

---

## Core Philosophy & Guardrails

### Physician Positioning Principles (user-provided verbatim)

- Private genomic intelligence **for the individual**, not a diagnostic service.
- Strict 5 core questions structure for **every** synthesized profile.
- Heavy emphasis on probabilistic/humility language: "tendency", "one data point among many", "not deterministic", "multifactorial", "consult professionals".
- GA4GH and ethical framing.
- Explicit notes on ancestry bias (most GWAS European-biased).
- **No hype, no disease claims, no "you have X"**.
- Repeated reinforcement: "no deterministic language", exact 5Qs, "probabilistic and humble".

### The Exact 5 Core Questions (enforced in every profile)

1. What might this mean?
2. How strong is the evidence?
3. Clinically established or exploratory?
4. Meaningful effect on lifestyle or metabolism/recovery/etc.?
5. Actionable or worth discussing with a professional?

Every answer must be framed probabilistically, note ancestry limitations, and end with the reminder that findings are "one data point among many" and that users should "consult your physician or genetic counselor."

### Evidence Transparency Standard

All findings surface:
- Evidence level / strength
- Effect size
- Ancestry considerations ("European-biased" etc.)
- Clinical status ("Exploratory", "Established for specific pairs", etc.)

This is implemented via the reusable `EvidenceBadge` component (multi-part labels such as "Moderate Evidence • Modest Influence • European-biased • Exploratory") plus a consistent legend.

---

## Approved Roadmap

User explicitly approved the following phased plan (verbatim): "Yes sounds really good... do b a and c... do them all... in that order please"

**a) Evidence & transparency first**
- `EvidenceBadge` component with multi-part labels.
- Legend.
- Consistent use across SNP table + all profiles.
- Knowledge base expansion with `evidenceLevel`, `references`, `clinicalActionability`, `notes`, `evidenceStrength`, `effectSize`, `ancestryNote`, `clinicalStatus`, `knowledgeBaseVersion`.

**b) Synthesis & depth**
- Four rich profiles using the **exact** 5Qs.
- "Why This Profile Matters" boxes.
- Progressive disclosure ("Show detailed SNPs").
- Richer limitations/details with genotype context + ancestry caveats.

**c) Trust Architecture**
- Dedicated `/for-clinicians` route.
- Expanded `OurApproach.tsx` (4 commitments + detailed privacy hero + For Clinicians CTA).
- Global `FirstVisitDisclaimer` banner (localStorage, calm guardrails).
- Trust links everywhere (nav, footer, profile footers).
- Export improvements that carry humility language and synthesized profiles.

**Subsequent beta readiness polish** (user: "complete the Beta Readiness items... final pre-beta polish... upgrade all four... Improve the PDF... Add a short Report Overview") included:
- KB v4 sleep SNPs (PER2 rs934945, MTNR1B rs10830963 + enhanced CLOCK) with full metadata.
- All 4 profiles upgraded to richer Phase 4 content.
- PDF: Report Overview summary + stricter page-break logic.
- exportUtils updated for richer Markdown.
- Feedback modal (localStorage only, no genomic data stored).
- Mobile/a11y polish on sub-selectors.

---

## Phase 5: Expert Critical Appraisals, Ancestry Transparency (Step 1), Gene–Environment Grounding (Step 2), Targeted Reframing of Weak-Signal Profiles (Step 3), and Educational Simulator Redesign (late May 2026)

After the core four phases and beta-readiness polish, the project entered a deliberate Phase 5 of expert-driven refinement. The user (a family physician) commissioned a panel of five specialists for independent critical appraisal of the tool's SNP selection, synthesis logic, limitations communication, ancestry handling, and overall framing:

- Bioethicist / population genetics (Okoro)
- Sleep medicine & circadian (Reyes)
- Statistical genetics / PRS (Vargas)
- Pharmacogenomics (Hale)
- Nutrition & metabolism (Sharma)

Raw reports were compiled into `EXPERT_CRITICAL_APPRAISALS_2026-05-27.md` (77 KB). These were synthesized into prioritized tiers with strong emphasis on consensus high-impact, low-risk improvements.

User directive (verbatim): "Please complete the full 'Do immediately' high-priority items systematically, one at a time" and repeated "Yes please proceed" / "full approvals" / "I think execute step 3" / "Yes please move to this next priority item" after each slice, with explicit instruction to circle back once complete.

### Step 1 – Finish ancestry communication (Tier 1 high-consensus)

- Added prominent global ancestry banner (exact text): "Important: Most genetic associations in this report are based primarily on European-ancestry studies. Applicability to other ancestries may be limited or unknown. Results should be interpreted with caution in non-European populations."
- Extended `EvidenceBadge` with `population` prop and reinforced legend entry for "Population applicability".
- Updated all four synthesized profiles (MethylationSupport, DrugMetabolismTendencies, NutritionMetabolismContext, SleepRecoveryContext) with the population note on every EvidenceBadge + strengthened ancestry language in 5Qs, Why boxes, and Limitations.
- Added dedicated "Ancestry and Population Considerations" section to `/for-clinicians` using the exact banner text.
- Strengthened Report Overview in PDF exports (pdfExport.ts) with explicit ancestry language.
- Live SHAs at completion of Step 1 (pre-gene-env): profiles 417b767f..., 3c183541..., cb0d2f75..., 04ef5dca...; page.tsx 5fdccc1f...; EvidenceBadge 274aee50...; pdfExport 8fe0ce33...; etc.

### Deep pre-change ancestry applicability analysis (non-European populations)

Before finalizing the ancestry updates, the user explicitly requested the pre-change state analysis: "I was asking the question before a change was made... answer the question asked before making changes."

The 5-expert panel was brought together on this exact point. Key synthesis:
- Most GWAS (including many of the 80+ SNPs) are European-biased; effect sizes and allele frequencies often do not port well (30–70% drop in predictive performance cited in literature).
- For weak signals (many of the sleep, nutrition, and wellness SNPs), the models are essentially "toy models" — useful for education and conversation starters but not calibrated for individuals outside the discovery populations.
- Stronger clinical signals (certain PGx pairs such as CYP2C19-clopidogrel, VKORC1-warfarin, and ALDH2 alcohol flush in East Asians) have clearer cross-ancestry relevance in some cases, but even these have exceptions and require clinical correlation.
- Top issues raised across the panel: systematic disclaimers required; no claim of equivalent applicability; environment usually dominates; consumer arrays have incomplete coverage for many ancestry-specific variants; risk of over-interpretation or anchoring; need for explicit "what this does not mean" language.

"What the tool can do" for non-European users: surface the matched raw SNPs with their metadata, apply the consistent 5Qs + humility framing, provide educational exports, and serve as a conversation starter with a clinician.

"What the tool cannot do": claim equivalent effect sizes or applicability, generate calibrated risk scores, override the dominance of environment/behavior, or substitute for validated clinical or ancestry-specific testing.

User response after the full panel synthesis: "Ok am very content and pleased with this discussion... please proceed with the next steps of the improvements as planned."

### Transition to Step 2 – Gene–environment dominance + grounded usefulness (Tier 1)

Next immediate priority (per the approved "Do immediately" list and expert consensus): add concise, visible gene–environment dominance callouts and explicit "what this does not mean" boundaries throughout the four profiles, KB entries where relevant, Report Overview, and exports.

Core framing (applied consistently): Environmental factors (diet quality, physical activity, sleep hygiene, medications, stress, light exposure, gut microbiome, etc.) typically explain the large majority of real-world variance for the traits discussed. The genetic signals surfaced here are one small, probabilistic contribution at best. Findings do not predict an individual's actual [methylation status / drug response / sleep quality / body weight / etc.]; they do not override lifestyle or environment; and they remain subject to the same ancestry and coverage limitations already disclosed.

This "grounded usefulness" lens ensures the tool remains educational and humble rather than creating false precision or anchoring.

Work on Step 2 (systematic, one profile at a time) began immediately after this history update. Todo discipline maintained: exactly one item in_progress at a time; circle back to user after each major slice. All four profiles received amber-bordered "Gene–Environment Context" callout boxes with reinforced language; for-clinicians and PDF Report Overview were also updated.

### Step 3 – Reframe DrugMetabolismTendencies and SleepRecoveryContext per expert critical appraisals (toy model / 90%+ environment dominance, narrow weak signals) (late May 2026)

After completion of Step 2 gene–environment callouts (with full user approvals and "no adjustment needed"), the user directed: "I think execute step 3".

Expert basis (synthesized from `EXPERT_CRITICAL_APPRAISALS_2026-05-27.md`, 77 KB raw reports):

- **Sleep medicine & circadian (Reyes)**: The 3-SNP model (CLOCK rs1801260/rs2305160, PER2 rs934945, MTNR1B rs10830963) captures <<2% of variance in sleep timing preferences. Large GWAS-derived PRS for chronotype reach only ~5–8% R² in Europeans; the large majority (typically 90%+) of differences are environmental/behavioral (light exposure, age, social schedules, stress, screen time). Strong recommendation for explicit "toy model / educational illustration only" framing, gene × environment emphasis cards, concrete modifiable levers (consistent morning bright light within 30–60 min of waking and dim evening lighting can shift timing 1–3+ hours; social jetlag of even 1–2 hours often dwarfs genetic signals), and "What this cannot tell you" language. Behavior usually moves the needle far more.

- **Statistical genetics / PRS (Vargas) + Pharmacogenomics (Hale)**: For DrugMetabolismTendencies, specific CPIC-supported pairs (CYP2C19*2-clopidogrel, VKORC1-warfarin) retain higher actionability, but overall drug response remains multifactorial — age, organ function, comedications, adherence, and comorbidities typically dominate. Consumer coverage gaps (CYP2D6/CYP3A4) are already well caveated. Recommendation to narrow the broader panel framing to a "toy model / educational illustration only," strengthen 90%+ clinical-factor dominance language, and tie any feedback to real modifiable levers (prescriber discussion, adherence, therapeutic monitoring) rather than over-weighting the limited common-variant signals.

Both profiles already contained the Step 2 gene–environment callouts. Step 3 further tightened the weak-signal profiles with explicit toy-model language, stronger quantitative humility (90%+ dominance), and direct ties to actionable levers while preserving the exact 5Qs structure, Why boxes, EvidenceBadges (with population notes), progressive disclosure, full Limitations panels, probabilistic tone, and trust footers.

**Changes implemented (live on GitHub):**

- **DrugMetabolismTendencies.tsx** (new file SHA `ea205b968372276e4fa1d36be39ad3c53f000ecb`; commit `8024984d49d7956e114a2106aaa53e686d1c6d13`):
  - Subtitle updated to "Narrow educational view of common pharmacogene indicators."
  - Gene–Environment Context box strengthened: explicit "toy model for education," "large majority of variability" from clinical factors (age, liver/kidney function, comedications, adherence, comorbidities, microbiome), "one small, probabilistic contribution at best," "does not predict your actual response."
  - Profile summary and 5Qs (especially Q1, Q4, Q5) tightened with panel-bounding language and emphasis on modifiable clinical levers (adherence, prescriber discussion, therapeutic monitoring).
  - Limitations list now leads with the toy-model / narrow-panel framing and 90%+ clinical dominance before the existing coverage and ancestry bullets.

- **SleepRecoveryContext.tsx** (new file SHA `9c5b78277b1d7b41a0d5fe6c3681ebd53c684367`; commit `bc7dadacca3b78b8c8ae8df56a1b89a03d968cde`):
  - Subtitle updated to "Toy model / educational illustration of circadian indicators."
  - Gene–Environment Context box substantially expanded: explicit "toy model for educational illustration only," <<2% variance for the 3-SNP model, "large majority (typically 90%+) are environmental and behavioral," concrete levers (morning bright light 30–60 min after waking + dim evening lighting can shift timing by 1–3+ hours; social jetlag of 1–2 hours often dwarfs genetics), "behavior usually moves the needle far more," "genetic slice is typically minutes or less."
  - Profile summary and 5Qs (especially Q1, Q4, Q5) updated with variance humility and direct tie to modifiable levers (light hygiene, consistent schedules, stress management).
  - Limitations list now leads with the toy-model + 90%+ env dominance + specific levers before the existing ancestry/polygenicity bullets.

All prior guardrails were strictly upheld: exact 5 core questions structure preserved in both profiles, probabilistic/humility language only ("one data point among many," "toy model for educational illustration only," "typically explain the large majority," "behavior usually moves the needle far more," "consult your prescriber/clinician"), no deterministic or diagnostic claims, client-side execution only, EvidenceBadge + Limitations + trust footer intact, and no storage of genomic data.

User had given repeated full approvals for the prior steps ("Yes please proceed no adjustment needed," "full approvals," "I think execute step 3") immediately before this work. Todo discipline maintained throughout (exactly one item in_progress at a time).

Live SHAs after Step 3 profile reframes (delivered in this initial commit):
- DrugMetabolismTendencies.tsx: ea205b968372276e4fa1d36be39ad3c53f000ecb
- SleepRecoveryContext.tsx: 9c5b78277b1d7b41a0d5fe6c3681ebd53c684367

### Educational Simulator Redesign (Phase 5 follow-up per expert appraisals) (late May 2026)

After Step 3, the next priority (per repeated expert consensus in the 2026-05-27 appraisals, especially Reyes, Vargas, Hale, and statistical/bioethics reviewers) was redesign of the broad "ILLUSTRATIVE GENETIC WELLNESS INDEX" gauge and simulation system in app/page.tsx.

The broad 0-100 gauge mixed high-evidence PGx with weak exploratory SNPs. Experts flagged high risk of anchoring and illusion of precision on low-variance signals (sleep model <<2% variance; nutrition often <4%). 

**Redesign delivered in this commit:** Replaced the broad wellness gauge with a narrowly scoped **"EDUCATIONAL PGx TOY MODEL — High-Evidence Pharmacogene Signals Only"** card (CYP2C19*2, VKORC1, etc. only). Added dominant 90%+ environment/clinical bar + tiny genetic sliver, explicit "toy model for education/illustration only — not a prediction", concrete levers, "what this cannot tell you", and updated feature bar. Full details and rationale in the top "CURRENT STATUS" section above.

All prior detailed build history, architecture decisions, and war stories from earlier Grok Builder sessions are summarized in the Executive Summary + Core Philosophy sections. The Key Files snapshot below reflects the complete initial public release.

---

## Key Files & Current State Snapshot (initial GitHub publish + handoff update, late May 2026)

| Path | Purpose | Recent SHA (full or short) |
|------|---------|----------------------------|
| `app/page.tsx` | Main SPA: upload, analysis, all 4 profiles wired, exports, feedback, nav + global ancestry banner; broad wellness gauge removed, narrow high-evidence PGx toy model added | `8b02239bc11dd6e13174c63544be8025af5b3ed2` |
| `lib/knowledgeBase.ts` | Static curated SNPs (~80) with full professional metadata | `23af5773d820ae5c...` |
| `lib/exportUtils.ts` | toJSON/toCSV/toMarkdown + richer Phase 4/5 synthesized profiles | `ef803710be6ff9dd84eed251fd8be68002be0f53` |
| `lib/pdfExport.ts` | jsPDF generator with Report Overview + strict page-breaks (ancestry language) | `d7292fe42abcd9f0966c971ea098dbd7eab528a4` |
| `components/profiles/MethylationSupport.tsx` | Rich Phase 4 profile + population note + gene-env callout (Step 2) | `1308c00ad15cf109bf932c5056529a0f36161603` |
| `components/profiles/DrugMetabolismTendencies.tsx` | Rich Phase 4 profile + population note + gene-env callout (Step 2) + Step 3 toy model / 90%+ clinical dominance reframing | `ea205b968372276e4fa1d36be39ad3c53f000ecb` |
| `components/profiles/NutritionMetabolismContext.tsx` | Rich Phase 4 profile + population note + gene-env callout (Step 2) | `e7cecae93743500a2495851a1fc41981864621f2` |
| `components/profiles/SleepRecoveryContext.tsx` | Rich Phase 4 profile + population note + gene-env callout (Step 2) + Step 3 explicit toy model / 90%+ env dominance + concrete levers reframing | `9c5b78277b1d7b41a0d5fe6c3681ebd53c684367` |
| `components/EvidenceBadge.tsx` | Reusable multi-part evidence labels + population legend | `274aee50dd16cb87...` |
| `app/for-clinicians/page.tsx` | Dedicated clinician guidance route (ancestry section + full Ancestry & PRS Limitations from expert synthesis) | `8c6a057dcb6bc594b7d7675d5569f42a3c7bc899` |
| ... | ... | ... |

**Additional important files:** `app/layout.tsx`, `app/globals.css`, `components/SNPTable.tsx`, `components/CategoryCard.tsx`, `components/DNAHelix.tsx`, `components/SupportModal.tsx`, `EXPERT_CRITICAL_APPRAISALS_2026-05-27.md` (77 KB).

---

## Footer

**Document created:** May 27, 2026 (PT) by Grok Document Curator subagent per explicit user request.  
**Updated:** late May 2026 (PT) with Phase 5 Step 3 profile reframes, curator append, educational simulator redesign, initial GitHub publish as a single atomic snapshot, and this handoff/resumption section for seamless cross-machine Grok Builder continuity. Current main HEAD: `7f0408cb29914554a503f8ed7246367cb01cace0`.  
**Source of truth:** Live GitHub repository at `smeagster86/grok-genome`.  
**Raw file URL:** https://raw.githubusercontent.com/smeagster86/grok-genome/main/DEVELOPMENT_HISTORY.md  
**Blob view:** https://github.com/smeagster86/grok-genome/blob/main/DEVELOPMENT_HISTORY.md

This document should be updated whenever major new phases, guardrail clarifications, or hard technical decisions occur.

*One data point among many. Built with care and radical respect for personal genomic data.*
